Skip to main content
Top
Published in: Virology Journal 1/2007

Open Access 01-12-2007 | Research

The simultaneous presence and expression of human hepatitis C virus (HCV), human herpesvirus-6 (HHV-6), and human immunodeficiency virus-1 (HIV-1) in a single human T-cell

Authors: S Zaki Salahuddin, Katherine A Snyder, Andre Godwin, Renu Grewal, John G Prichard, Ann S Kelley, Dennis Revie

Published in: Virology Journal | Issue 1/2007

Login to get access

Abstract

We have developed a system that isolates and replicates HCV in vitro. These isolates are called CIMM-HCV. This system has made it possible to analyze the biology, nature, and extent of HCV variability, among other things. Individuals that are infected with HIV-1 are often also infected with HCV and HHV-6. In addition to HCV, our lab has systems for replicating HIV-1 and HHV-6. We asked whether all these viruses could infect the same cells. We report here the successful infection of a T-cell (CEM) by CIMM-HCV, HHV-6, and HIV-1. PCR analyses demonstrated that the CEM cells were productively infected by HHV-6A. RT-PCR showed that the same cell culture was positive for HCV and HIV-1. Co-infection of a T-cell by all three viruses was confirmed by transmission electron microscopy (TEM). All these viruses are highly cytolytic; therefore, triply-infected cells were short lived. However, HIV-1 and HCV co-infected cells unexpectedly lasted for several weeks. Viral replication was unhindered and the phenomenon of 'dominance' was not observed in our experiments. In addition, CIMM-HCV was present in the perinuclear space, suggesting their possible synthesis in the nucleus. This report is based entirely on viruses produced in vitro in our laboratories. As part of the determinations of host ranges of these viruses, studies were designed to demonstrate the infection of a single cell by these viruses and to study the consequences of this phenomenon. All measurements were made on cultured cells and cell culture supernatants.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sherman KE, Rouster SD, Chung RT, Rajicic N: Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis. 2002, 34 (6): 831-837. 10.1086/339042.PubMedCrossRef Sherman KE, Rouster SD, Chung RT, Rajicic N: Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis. 2002, 34 (6): 831-837. 10.1086/339042.PubMedCrossRef
2.
go back to reference Winnock M, Salmon-Ceron D, Dabis F, Chene G: Interaction between HIV-1 and HCV infections: towards a new entity?. J Antimicrob Chemother. 2004, 53 (6): 936-946. 10.1093/jac/dkh200.PubMedCrossRef Winnock M, Salmon-Ceron D, Dabis F, Chene G: Interaction between HIV-1 and HCV infections: towards a new entity?. J Antimicrob Chemother. 2004, 53 (6): 936-946. 10.1093/jac/dkh200.PubMedCrossRef
3.
go back to reference Jones R, Dunning J, Nelson M: HIV and hepatitis C co-infection. Int J Clin Pract. 2005, 59 (9): 1082-1087. 10.1111/j.1742-1241.2005.00596.x.PubMedCrossRef Jones R, Dunning J, Nelson M: HIV and hepatitis C co-infection. Int J Clin Pract. 2005, 59 (9): 1082-1087. 10.1111/j.1742-1241.2005.00596.x.PubMedCrossRef
4.
go back to reference Schooley RT: HIV and hepatitis C virus coinfection: bad bedfellows. Top HIV Med. 2005, 13 (4): 112-116.PubMed Schooley RT: HIV and hepatitis C virus coinfection: bad bedfellows. Top HIV Med. 2005, 13 (4): 112-116.PubMed
5.
go back to reference Revie D, Braich RS, Bayles D, Chelyapov N, Khan R, Geer C, Reisman R, Kelley AS, Prichard JG, Salahuddin SZ: Transmission of human hepatitis C virus from patients in secondary cells for long term culture. Virol J. 2005, 2: 37-10.1186/1743-422X-2-37.PubMedPubMedCentralCrossRef Revie D, Braich RS, Bayles D, Chelyapov N, Khan R, Geer C, Reisman R, Kelley AS, Prichard JG, Salahuddin SZ: Transmission of human hepatitis C virus from patients in secondary cells for long term culture. Virol J. 2005, 2: 37-10.1186/1743-422X-2-37.PubMedPubMedCentralCrossRef
6.
go back to reference Revie D, Alberti MO, Braich RS, Chelyapov N, Bayles D, Prichard JG, Salahuddin SZ: Analysis of in vitro replicated human hepatitis C virus (HCV) for the determination of genotypes and quasispecies. Virol J. 2006, 3: 81-10.1186/1743-422X-3-81.PubMedPubMedCentralCrossRef Revie D, Alberti MO, Braich RS, Chelyapov N, Bayles D, Prichard JG, Salahuddin SZ: Analysis of in vitro replicated human hepatitis C virus (HCV) for the determination of genotypes and quasispecies. Virol J. 2006, 3: 81-10.1186/1743-422X-3-81.PubMedPubMedCentralCrossRef
7.
go back to reference Revie D, Alberti MO, Braich RS, Bayles D, Prichard JG, Salahuddin SZ: Discovery of significant variants containing large deletions in the 5'UTR of human hepatitis C virus (HCV). Virol J. 2006, 3: 82-10.1186/1743-422X-3-82.PubMedPubMedCentralCrossRef Revie D, Alberti MO, Braich RS, Bayles D, Prichard JG, Salahuddin SZ: Discovery of significant variants containing large deletions in the 5'UTR of human hepatitis C virus (HCV). Virol J. 2006, 3: 82-10.1186/1743-422X-3-82.PubMedPubMedCentralCrossRef
8.
go back to reference Torres-Puente M, Cuevas JM, Jimenez-Hernandez N, Bracho MA, Garcia-Robles I, Carnicer F, del Olmo J, Ortega E, Moya A, Gonzalez-Candelas F: Contribution of insertions and deletions to the variability of hepatitis C virus populations. J Gen Virol. 2007, 88 (Pt 8): 2198-2203. 10.1099/vir.0.82855-0.PubMedCrossRef Torres-Puente M, Cuevas JM, Jimenez-Hernandez N, Bracho MA, Garcia-Robles I, Carnicer F, del Olmo J, Ortega E, Moya A, Gonzalez-Candelas F: Contribution of insertions and deletions to the variability of hepatitis C virus populations. J Gen Virol. 2007, 88 (Pt 8): 2198-2203. 10.1099/vir.0.82855-0.PubMedCrossRef
9.
go back to reference Salahuddin SZ, Markham PD, Popovic M, Sarngadharan MG, Orndorff S, Fladagar A, Patel A, Gold J, Gallo RC: Isolation of infectious human T-cell leukemia/lymphotropic virus type III (HTLV-III) from patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) and from healthy carriers: a study of risk groups and tissue sources. Proc Natl Acad Sci U S A. 1985, 82 (16): 5530-5534. 10.1073/pnas.82.16.5530.PubMedPubMedCentralCrossRef Salahuddin SZ, Markham PD, Popovic M, Sarngadharan MG, Orndorff S, Fladagar A, Patel A, Gold J, Gallo RC: Isolation of infectious human T-cell leukemia/lymphotropic virus type III (HTLV-III) from patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) and from healthy carriers: a study of risk groups and tissue sources. Proc Natl Acad Sci U S A. 1985, 82 (16): 5530-5534. 10.1073/pnas.82.16.5530.PubMedPubMedCentralCrossRef
10.
go back to reference Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M, Halligan G, Biberfeld P, Wong-Staal F, Kramarsky B, et al: Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science. 1986, 234 (4776): 596-601. 10.1126/science.2876520.PubMedCrossRef Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M, Halligan G, Biberfeld P, Wong-Staal F, Kramarsky B, et al: Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science. 1986, 234 (4776): 596-601. 10.1126/science.2876520.PubMedCrossRef
11.
go back to reference Salahuddin SZ, Rose RM, Groopman JE, Markham PD, Gallo RC: Human T lymphotropic virus type III infection of human alveolar macrophages. Blood. 1986, 68 (1): 281-284.PubMed Salahuddin SZ, Rose RM, Groopman JE, Markham PD, Gallo RC: Human T lymphotropic virus type III infection of human alveolar macrophages. Blood. 1986, 68 (1): 281-284.PubMed
12.
go back to reference Shimizu YK, Feinstone SM, Kohara M, Purcell RH, Yoshikura H: Hepatitis C virus: detection of intracellular virus particles by electron microscopy. Hepatology. 1996, 23 (2): 205-209. 10.1002/hep.510230202.PubMedCrossRef Shimizu YK, Feinstone SM, Kohara M, Purcell RH, Yoshikura H: Hepatitis C virus: detection of intracellular virus particles by electron microscopy. Hepatology. 1996, 23 (2): 205-209. 10.1002/hep.510230202.PubMedCrossRef
13.
go back to reference Steffan A, Marianneau P, Caussin-Schwemling C, Royer C, Schmitt C, Jaeck D, Wolf P, Gendrault J, Stoll-Keller F: Ultrastructural observations in hepatitis C virus-infected lymphoid cells. Microbes Infect. 2001, 3 (3): 193-202. 10.1016/S1286-4579(01)01369-7.PubMedCrossRef Steffan A, Marianneau P, Caussin-Schwemling C, Royer C, Schmitt C, Jaeck D, Wolf P, Gendrault J, Stoll-Keller F: Ultrastructural observations in hepatitis C virus-infected lymphoid cells. Microbes Infect. 2001, 3 (3): 193-202. 10.1016/S1286-4579(01)01369-7.PubMedCrossRef
14.
go back to reference Vallet-Pichard A, Pol S: Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection. J Hepatol. 2006, 44 (1 Suppl): S28-34. 10.1016/j.jhep.2005.11.008.PubMedCrossRef Vallet-Pichard A, Pol S: Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection. J Hepatol. 2006, 44 (1 Suppl): S28-34. 10.1016/j.jhep.2005.11.008.PubMedCrossRef
15.
go back to reference Greub G, Ledergerber B, Battegay M, Grob P, Perrin L, Furrer H, Burgisser P, Erb P, Boggian K, Piffaretti JC, Hirschel B, Janin P, Francioli P, Flepp M, Telenti A: Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet. 2000, 356 (9244): 1800-1805. 10.1016/S0140-6736(00)03232-3.PubMedCrossRef Greub G, Ledergerber B, Battegay M, Grob P, Perrin L, Furrer H, Burgisser P, Erb P, Boggian K, Piffaretti JC, Hirschel B, Janin P, Francioli P, Flepp M, Telenti A: Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet. 2000, 356 (9244): 1800-1805. 10.1016/S0140-6736(00)03232-3.PubMedCrossRef
16.
go back to reference De Luca A, Bugarini R, Lepri AC, Puoti M, Girardi E, Antinori A, Poggio A, Pagano G, Tositti G, Cadeo G, Macor A, Toti M, D'Arminio Monforte A: Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects. Arch Intern Med. 2002, 162 (18): 2125-2132. 10.1001/archinte.162.18.2125.PubMedCrossRef De Luca A, Bugarini R, Lepri AC, Puoti M, Girardi E, Antinori A, Poggio A, Pagano G, Tositti G, Cadeo G, Macor A, Toti M, D'Arminio Monforte A: Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects. Arch Intern Med. 2002, 162 (18): 2125-2132. 10.1001/archinte.162.18.2125.PubMedCrossRef
17.
go back to reference Law WP, Duncombe CJ, Mahanontharit A, Boyd MA, Ruxrungtham K, Lange JM, Phanuphak P, Cooper DA, Dore GJ: Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort. Aids. 2004, 18 (8): 1169-1177. 10.1097/00002030-200405210-00010.PubMedCrossRef Law WP, Duncombe CJ, Mahanontharit A, Boyd MA, Ruxrungtham K, Lange JM, Phanuphak P, Cooper DA, Dore GJ: Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort. Aids. 2004, 18 (8): 1169-1177. 10.1097/00002030-200405210-00010.PubMedCrossRef
18.
go back to reference Sullivan PS, Hanson DL, Teshale EH, Wotring LL, Brooks JT: Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy. Aids. 2006, 20 (8): 1171-1179. 10.1097/01.aids.0000226958.87471.48.PubMedCrossRef Sullivan PS, Hanson DL, Teshale EH, Wotring LL, Brooks JT: Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy. Aids. 2006, 20 (8): 1171-1179. 10.1097/01.aids.0000226958.87471.48.PubMedCrossRef
19.
go back to reference Laskus T, Radkowski M, Jablonska J, Kibler K, Wilkinson J, Adair D, Rakela J: Human immunodeficiency virus facilitates infection/replication of hepatitis C virus in native human macrophages. Blood. 2004, 103 (10): 3854-3859. 10.1182/blood-2003-08-2923.PubMedCrossRef Laskus T, Radkowski M, Jablonska J, Kibler K, Wilkinson J, Adair D, Rakela J: Human immunodeficiency virus facilitates infection/replication of hepatitis C virus in native human macrophages. Blood. 2004, 103 (10): 3854-3859. 10.1182/blood-2003-08-2923.PubMedCrossRef
20.
go back to reference Lusso P, Ensoli B, Markham PD, Ablashi DV, Salahuddin SZ, Tschachler E, Wong-Staal F, Gallo RC: Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6. Nature. 1989, 337 (6205): 370-373. 10.1038/337370a0.PubMedCrossRef Lusso P, Ensoli B, Markham PD, Ablashi DV, Salahuddin SZ, Tschachler E, Wong-Staal F, Gallo RC: Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6. Nature. 1989, 337 (6205): 370-373. 10.1038/337370a0.PubMedCrossRef
21.
go back to reference Asada H, Klaus-Kovtun V, Golding H, Katz SI, Blauvelt A: Human herpesvirus 6 infects dendritic cells and suppresses human immunodeficiency virus type 1 replication in coinfected cultures. J Virol. 1999, 73 (5): 4019-4028.PubMedPubMedCentral Asada H, Klaus-Kovtun V, Golding H, Katz SI, Blauvelt A: Human herpesvirus 6 infects dendritic cells and suppresses human immunodeficiency virus type 1 replication in coinfected cultures. J Virol. 1999, 73 (5): 4019-4028.PubMedPubMedCentral
22.
go back to reference Csoma E, Deli T, Konya J, Csernoch L, Beck Z, Gergely L: Human herpesvirus 6A decreases the susceptibility of macrophages to R5 variants of human immunodeficiency virus 1: possible role of RANTES and IL-8. Virus Res. 2006, 121 (2): 161-168. 10.1016/j.virusres.2006.05.007.PubMedCrossRef Csoma E, Deli T, Konya J, Csernoch L, Beck Z, Gergely L: Human herpesvirus 6A decreases the susceptibility of macrophages to R5 variants of human immunodeficiency virus 1: possible role of RANTES and IL-8. Virus Res. 2006, 121 (2): 161-168. 10.1016/j.virusres.2006.05.007.PubMedCrossRef
23.
go back to reference Radkowski M, Wilkinson J, Nowicki M, Adair D, Vargas H, Ingui C, Rakela J, Laskus T: Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J Virol. 2002, 76 (2): 600-608. 10.1128/JVI.76.2.600-608.2002.PubMedPubMedCentralCrossRef Radkowski M, Wilkinson J, Nowicki M, Adair D, Vargas H, Ingui C, Rakela J, Laskus T: Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J Virol. 2002, 76 (2): 600-608. 10.1128/JVI.76.2.600-608.2002.PubMedPubMedCentralCrossRef
24.
go back to reference Letendre S, Paulino AD, Rockenstein E, Adame A, Crews L, Cherner M, Heaton R, Ellis R, Everall IP, Grant I, Masliah E: Pathogenesis of Hepatitis C Virus Coinfection in the Brains of Patients Infected with HIV. J Infect Dis. 2007, 196 (3): 361-370. 10.1086/519285.PubMedCrossRef Letendre S, Paulino AD, Rockenstein E, Adame A, Crews L, Cherner M, Heaton R, Ellis R, Everall IP, Grant I, Masliah E: Pathogenesis of Hepatitis C Virus Coinfection in the Brains of Patients Infected with HIV. J Infect Dis. 2007, 196 (3): 361-370. 10.1086/519285.PubMedCrossRef
25.
go back to reference An SF, Giometto B, Scaravilli F: HIV-1 DNA in brains in AIDS and pre-AIDS: correlation with the stage of disease. Ann Neurol. 1996, 40 (4): 611-617. 10.1002/ana.410400411.PubMedCrossRef An SF, Giometto B, Scaravilli F: HIV-1 DNA in brains in AIDS and pre-AIDS: correlation with the stage of disease. Ann Neurol. 1996, 40 (4): 611-617. 10.1002/ana.410400411.PubMedCrossRef
26.
go back to reference Glass JD, Fedor H, Wesselingh SL, McArthur JC: Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol. 1995, 38 (5): 755-762. 10.1002/ana.410380510.PubMedCrossRef Glass JD, Fedor H, Wesselingh SL, McArthur JC: Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol. 1995, 38 (5): 755-762. 10.1002/ana.410380510.PubMedCrossRef
27.
go back to reference Johnson RT, Glass JD, McArthur JC, Chesebro BW: Quantitation of human immunodeficiency virus in brains of demented and nondemented patients with acquired immunodeficiency syndrome. Ann Neurol. 1996, 39 (3): 392-395. 10.1002/ana.410390319.PubMedCrossRef Johnson RT, Glass JD, McArthur JC, Chesebro BW: Quantitation of human immunodeficiency virus in brains of demented and nondemented patients with acquired immunodeficiency syndrome. Ann Neurol. 1996, 39 (3): 392-395. 10.1002/ana.410390319.PubMedCrossRef
28.
go back to reference Isken O, Baroth M, Grassmann CW, Weinlich S, Ostareck DH, Ostareck-Lederer A, Behrens SE: Nuclear factors are involved in hepatitis C virus RNA replication. Rna. 2007 Isken O, Baroth M, Grassmann CW, Weinlich S, Ostareck DH, Ostareck-Lederer A, Behrens SE: Nuclear factors are involved in hepatitis C virus RNA replication. Rna. 2007
29.
go back to reference Hwang SB, Park KJ, Kim YS, Sung YC, Lai MM: Hepatitis C virus NS5B protein is a membrane-associated phosphoprotein with a predominantly perinuclear localization. Virology. 1997, 227 (2): 439-446. 10.1006/viro.1996.8357.PubMedCrossRef Hwang SB, Park KJ, Kim YS, Sung YC, Lai MM: Hepatitis C virus NS5B protein is a membrane-associated phosphoprotein with a predominantly perinuclear localization. Virology. 1997, 227 (2): 439-446. 10.1006/viro.1996.8357.PubMedCrossRef
30.
go back to reference El-Hage N, Luo G: Replication of hepatitis C virus RNA occurs in a membrane-bound replication complex containing nonstructural viral proteins and RNA. J Gen Virol. 2003, 84 (Pt 10): 2761-2769. 10.1099/vir.0.19305-0.PubMedCrossRef El-Hage N, Luo G: Replication of hepatitis C virus RNA occurs in a membrane-bound replication complex containing nonstructural viral proteins and RNA. J Gen Virol. 2003, 84 (Pt 10): 2761-2769. 10.1099/vir.0.19305-0.PubMedCrossRef
31.
go back to reference Dominguez-Villar M, Munoz-Suano A, Anaya-Baz B, Aguilar S, Novalbos JP, Giron JA, Rodriguez-Iglesias M, Garcia-Cozar F: Hepatitis C virus core protein up-regulates anergy-related genes and a new set of genes, which affects T cell homeostasis. J Leukoc Biol. 2007 Dominguez-Villar M, Munoz-Suano A, Anaya-Baz B, Aguilar S, Novalbos JP, Giron JA, Rodriguez-Iglesias M, Garcia-Cozar F: Hepatitis C virus core protein up-regulates anergy-related genes and a new set of genes, which affects T cell homeostasis. J Leukoc Biol. 2007
32.
go back to reference D.V. Ablashi HA: Human herpesvirus-6 strain groups: a nomenclature. Arch Virol. 1993, 129: 363-366. 10.1007/BF01316913.CrossRef D.V. Ablashi HA: Human herpesvirus-6 strain groups: a nomenclature. Arch Virol. 1993, 129: 363-366. 10.1007/BF01316913.CrossRef
33.
go back to reference Santiago ML, Bibollet-Ruche F, Bailes E, Kamenya S, Muller MN, Lukasik M, Pusey AE, Collins DA, Wrangham RW, Goodall J, Shaw GM, Sharp PM, Hahn BH: Amplification of a complete simian immunodeficiency virus genome from fecal RNA of a wild chimpanzee. J Virol. 2003, 77 (3): 2233-2242. 10.1128/JVI.77.3.2233-2242.2003.PubMedPubMedCentralCrossRef Santiago ML, Bibollet-Ruche F, Bailes E, Kamenya S, Muller MN, Lukasik M, Pusey AE, Collins DA, Wrangham RW, Goodall J, Shaw GM, Sharp PM, Hahn BH: Amplification of a complete simian immunodeficiency virus genome from fecal RNA of a wild chimpanzee. J Virol. 2003, 77 (3): 2233-2242. 10.1128/JVI.77.3.2233-2242.2003.PubMedPubMedCentralCrossRef
34.
go back to reference Mirandola P, Menegazzi P, Merighi S, Ravaioli T, Cassai E, Di Luca D: Temporal mapping of transcripts in herpesvirus 6 variants. J Virol. 1998, 72 (5): 3837-3844.PubMedPubMedCentral Mirandola P, Menegazzi P, Merighi S, Ravaioli T, Cassai E, Di Luca D: Temporal mapping of transcripts in herpesvirus 6 variants. J Virol. 1998, 72 (5): 3837-3844.PubMedPubMedCentral
Metadata
Title
The simultaneous presence and expression of human hepatitis C virus (HCV), human herpesvirus-6 (HHV-6), and human immunodeficiency virus-1 (HIV-1) in a single human T-cell
Authors
S Zaki Salahuddin
Katherine A Snyder
Andre Godwin
Renu Grewal
John G Prichard
Ann S Kelley
Dennis Revie
Publication date
01-12-2007
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2007
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-4-106

Other articles of this Issue 1/2007

Virology Journal 1/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine